v3.26.3
Net Loss Per Share
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Net Loss Per Share Net Loss Per Share
Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:
Three Months Ended September 30,
 
Nine Months Ended September 30,
2026202520262025
Numerator:
Net loss$(129,279)$(173,443)$(397,122)$(593,267)
Denominator:
Weighted average common shares outstanding—basic and diluted151,040,349 105,815,038 149,776,602 103,391,267 
Net loss per share — basic and diluted$(0.86)$(1.64)$(2.65)$(5.74)
The Company's potential dilutive securities include share options which have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common shareholders of the Company is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:
As of September 30,
20262025
Options to purchase common shares20,264,906 15,799,622 
Warrants to purchase common shares— 294,195 
Restricted share units
888,236 1,414,446 
 Total21,153,142 17,508,263